www.lilly.com
Open in
urlscan Pro
54.161.241.46
Public Scan
Submitted URL: http://www.lillyventures.com/
Effective URL: https://www.lilly.com/partners
Submission: On October 08 via api from US — Scanned from DE
Effective URL: https://www.lilly.com/partners
Submission: On October 08 via api from US — Scanned from DE
Form analysis
0 forms found in the DOMText Content
Accessibility Statement Skip to main content This website uses cookies and other technologies to personalize content and ads on this and other websites and provide social media features. By clicking "I Agree" you consent to our use of tracking technologies and disclosure of tracking data to third party ad networks or social media companies for the purposes above. If you click "I Disagree" you can still use this website. For more information about Lilly's privacy practice and to manage third-party preferences, click here. I Disagree I Agree * ESG Report * Careers * Partners * Investors * Contact * Globe Lilly Menu Menu Menu closed Lilly Close Close * Company Expand mega menu Expand submenu Left Back Company WHO WE ARE Expand * About Lilly * Key Facts * Recognitions * Powered by Purpose LEADERSHIP Expand * Governance * Executive Committee * Board of Directors POLICIES & REPORTS Expand * Public Policy * Annual Report & Proxy Statement * Science Expand mega menu Expand submenu Left Back Science DISCOVERY Expand * Clinical Development Pipeline * Research & Scientific Discovery * Principles of Medical Research * The Elixir Factor Podcast * 100 Years of Insulin DISEASE AREAS Expand * Alzheimer's * Cancer * Diabetes * Immunology * Obesity * Pain CLINICAL RESEARCH Expand * Clinical Trials * Diversity in Clinical Trials * Lilly Trials * Expanded Access * CSR Synopses PARTNERS Expand * Collaborate With Us * Scientific Areas of Interest * Our Approach to Partnering * Office of Alliance Management * Lilly Research Award Program * Medicines Expand mega menu Expand submenu Left Back Medicines SAFETY Expand * Patient Safety * Medication Safety * Manufacturing & Quality OUR MEDICINES Expand * Current Medicines * Historic Medicines * Suggestions for Patients RESOURCES Expand * Lilly Diabetes Solution Center * Lilly Insulin State Patient Assistance Programs * Lilly Oncology Support Center * Lilly Pricing Information * The Lilly Answers Center * Lilly Cares Foundation * Impact Expand mega menu Expand submenu Left Back Impact OUR IMPACT Expand * Overview * Lilly Foundation * Lilly Grant Office IMPACT AREAS Expand * Increase Access to Medicines * Improve Lives and Communities * Empower a Diverse Workforce * Minimize Our Environmental Impact * Operate Ethically and Responsibly TRANSPARENCY Expand * ESG Report * State-Specific Requirements * News Expand mega menu Expand submenu Left Back News STORIES Expand * Caring * Science * Policy * All Stories PRESS RELEASES Expand * Recent * Archives MEDIA Expand * All News * Media Kits * Media Contacts * Social Media Guidelines * * Search * ESG Report * Careers * Partners * Investors * Contact * Globe SMART RISKS. BOLD SCIENCE. At Lilly, we take smart risks on bold science to bring life-changing medicines to patients. Let's Collaborate OUR APPROACH TO PARTNERING Learn More SCIENTIFIC AREAS OF INTEREST Learn More > Quotes > > > AS A COMMUNITY OF SCIENTISTS, WE APPRECIATE THE BRILLIANCE AND DEDICATION > REQUIRED TO UNCOVER THE NEXT POTENTIAL MEDICAL BREAKTHROUGHS. WE TAKE > SERIOUSLY OUR RESPONSIBILITY AS PARTNERS IN STEWARDING YOUR IDEA TO SUCCESS. > > Kenneth Custer, Ph.D.Head of Business Development 180+ Actively managed alliances 15/20 of Lilly’s last new launches enabled by external innovation 2B+ committed to biotech over the last 20 years through venture investing FIND LILLY AT UPCOMING EVENTS See where we will be next, and request a meeting. Partnering Events LILLY IN THE NEWS Lilly and Entos Pharmaceuticals Enter into Research and Collaboration Agreement to Support the Development of Innovative Therapies in Multiple Neurologic Indications January 6, 2022 -------------------------------------------------------------------------------- Lilly and Foghorn Announce Strategic Collaboration for Novel Oncology Targets Using Foghorn's Proprietary Gene Traffic Control® Platform December 13, 2021 -------------------------------------------------------------------------------- Lilly and Regor Therapeutics Group Enter into Strategic Collaboration to Discover and Develop Novel Therapies for Metabolic Disorders December 10, 2021 -------------------------------------------------------------------------------- Lilly and Lycia Therapeutics Enter into Strategic Collaboration to Discover and Develop Novel Lysosomal Targeting Chimera (LYTAC) Degraders August 25, 2021 -------------------------------------------------------------------------------- Lilly and Kumquat Biosciences Announce Collaboration to Discover and Develop Novel Small Molecules that Stimulate Tumor-Specific Immune Responses July 29, 2021 -------------------------------------------------------------------------------- MEET OUR OFFICE OF ALLIANCE MANAGEMENT Learn More GET IN TOUCH Tell us about your biotech innovation. Start the Conversation Diversity Contact Suppliers Login Terms of Use Privacy Statement Accessibility Statement Sitemap To speak to customer support: Call (800) 545-5979 This site is intended for U.S. residents ages 18 and older. Copyright © 2022 Lilly. All rights reserved. Twitter Facebook Instagram LinkedIn YouTube Terms of Use Privacy Statement Accessibility Statement Sitemap Lilly